A detailed history of Clearbridge Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clearbridge Investments, LLC holds 2,680,768 shares of NVO stock, worth $282 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
2,680,768
Previous 2,140,714 25.23%
Holding current value
$282 Million
Previous $306 Million 4.46%
% of portfolio
0.26%
Previous 0.26%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $64.3 Million - $78.5 Million
540,054 Added 25.23%
2,680,768 $319 Million
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $10.6 Million - $12.6 Million
-86,103 Reduced 3.87%
2,140,714 $306 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $8.93 Million - $11.9 Million
-87,444 Reduced 3.78%
2,226,817 $286 Million
Q4 2023

Feb 09, 2024

BUY
$87.78 - $105.45 $7.83 Million - $9.4 Million
89,152 Added 4.01%
2,314,261 $239 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $82.5 Million - $181 Million
907,561 Added 68.88%
2,225,109 $202 Million
Q2 2023

Aug 11, 2023

SELL
$155.98 - $172.65 $13.1 Million - $14.5 Million
-84,241 Reduced 6.01%
1,317,548 $213 Million
Q1 2023

May 12, 2023

SELL
$132.34 - $159.14 $3.31 Million - $3.98 Million
-25,027 Reduced 1.75%
1,401,789 $223 Million
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $45.5 Million - $60 Million
443,609 Added 45.12%
1,426,816 $193 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $6.38 Million - $7.83 Million
66,977 Added 7.31%
983,207 $98 Million
Q2 2022

Aug 11, 2022

SELL
$103.24 - $121.81 $34.8 Million - $41 Million
-336,878 Reduced 26.88%
916,230 $102 Million
Q1 2022

May 13, 2022

SELL
$93.1 - $112.54 $129 Million - $156 Million
-1,385,158 Reduced 52.5%
1,253,108 $139 Million
Q4 2021

Feb 11, 2022

SELL
$95.88 - $117.08 $10.2 Million - $12.5 Million
-106,740 Reduced 3.89%
2,638,266 $295 Million
Q3 2021

Nov 12, 2021

BUY
$84.42 - $106.62 $6.8 Million - $8.59 Million
80,560 Added 3.02%
2,745,006 $264 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $3.52 Million - $4.42 Million
52,097 Added 1.99%
2,664,446 $223 Million
Q1 2021

May 13, 2021

BUY
$67.06 - $75.82 $5.73 Million - $6.48 Million
85,433 Added 3.38%
2,612,349 $176 Million
Q4 2020

Feb 10, 2021

BUY
$63.89 - $73.8 $10.5 Million - $12.1 Million
163,748 Added 6.93%
2,526,916 $177 Million
Q3 2020

Nov 12, 2020

BUY
$63.69 - $70.22 $3.38 Million - $3.73 Million
53,109 Added 2.3%
2,363,168 $164 Million
Q2 2020

Aug 14, 2020

BUY
$58.54 - $67.94 $8.63 Million - $10 Million
147,425 Added 6.82%
2,310,059 $151 Million
Q1 2020

May 15, 2020

BUY
$49.46 - $64.78 $7.27 Million - $9.52 Million
146,914 Added 7.29%
2,162,634 $130 Million
Q4 2019

Feb 14, 2020

BUY
$49.86 - $58.26 $10.5 Million - $12.3 Million
210,689 Added 11.67%
2,015,720 $118 Million
Q3 2019

Nov 14, 2019

BUY
$47.54 - $53.43 $15.6 Million - $17.5 Million
327,836 Added 22.19%
1,805,031 $93.3 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $14.8 Million - $16.6 Million
316,253 Added 27.24%
1,477,195 $0
Q1 2019

May 15, 2019

BUY
$46.36 - $52.63 $16 Million - $18.2 Million
344,989 Added 42.28%
1,160,942 $60.7 Million
Q4 2018

Feb 14, 2019

BUY
$41.54 - $47.25 $7.12 Million - $8.1 Million
171,396 Added 26.59%
815,953 $37.6 Million
Q3 2018

Nov 14, 2018

BUY
$46.76 - $51.24 $9.6 Million - $10.5 Million
205,326 Added 46.75%
644,557 $30.4 Million
Q2 2018

Aug 14, 2018

BUY
$44.29 - $50.42 $2.88 Million - $3.27 Million
64,948 Added 17.35%
439,231 $20.3 Million
Q1 2018

May 15, 2018

SELL
$48.49 - $58.14 $5.11 Million - $6.13 Million
-105,476 Reduced 21.99%
374,283 $18.4 Million
Q4 2017

Feb 14, 2018

BUY
$47.53 - $53.73 $1.41 Million - $1.59 Million
29,610 Added 6.58%
479,759 $25.7 Million
Q3 2017

Nov 14, 2017

BUY
$41.15 - $49.22 $1.16 Million - $1.38 Million
28,128 Added 6.67%
450,149 $21.7 Million
Q2 2017

Aug 14, 2017

BUY
N/A
422,021
422,021 $18.1 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.